Nicotinic treatment of Alzheimer’s disease
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 49 (3), 268-278
- https://doi.org/10.1016/s0006-3223(00)01069-6
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- A randomized controlled trial of prednisone in Alzheimer’s diseaseNeurology, 2000
- Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's DiseaseCNS Drug Reviews, 1995
- Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21Brain Research, 1995
- Normalization of auditory physiology by cigarette smoking in schizophrenic patientsAmerican Journal of Psychiatry, 1993
- Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenicsBiological Psychiatry, 1992
- Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's DiseasesJournal of Neurochemistry, 1992
- Cognitive psychology and human memoryTrends in Neurosciences, 1988
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Nicotine-like behavioral effect after small dose of mecamylamine in roman high-avoidance ratsPsychopharmacology, 1976
- Human Memory and the Cholinergic SystemArchives of Neurology, 1974